EquityFlow
›
Companies
› ImpriMed
ImpriMed
Healthtech
· Palo Alto, US ·
imprimedicine.com
AI precision-medicine company predicting anti-cancer drug response (pet dogs with blood cancer).
Funding history
Date
Round
Amount
Nov 2023
Funding round
AI precision-medicine company ImpriMed, based in Silicon Valley, raised KRW 30B (~$23M).
$23M
Similar companies in Healthtech
OurMind
TurnUp
Nanordica Medical
Uncovr
01Health
Rem3dy Health
Joyvié Health
Semble
Triomics
Musely
VITL
Ema Health
Explore funding flow on EquityFlow →